2021
DOI: 10.3390/jcm10143112
|View full text |Cite
|
Sign up to set email alerts
|

Proinflammatory and Hepatic Features Related to Morbidity and Fatal Outcomes in COVID-19 Patients

Abstract: Objective: to screen putative associations between liver markers and proinflammatory-related features concerning infectious morbidity and fatal outcomes in COVID-19 patients. Methods: a total of 2094 COVID-19 positive patients from the COVID-DATA-SAFE-LIFES cohort (HM hospitals consortium) were classified according to median values of hepatic, inflammatory, and clinical indicators. Logistic regression models were fitted and ROC cures were generated to explain disease severity and mortality. Results: intensive … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 37 publications
4
16
0
Order By: Relevance
“…This association persisted in the multivariable survival model after adjustment for potential confounders and for the severity of respiratory failure. In particular, when we built the ROC curves for mortality, we found an AUC of 0.73 for the FIB-4 score that is in line with recent studies [ 23 , 24 ].…”
Section: Discussionsupporting
confidence: 90%
“…This association persisted in the multivariable survival model after adjustment for potential confounders and for the severity of respiratory failure. In particular, when we built the ROC curves for mortality, we found an AUC of 0.73 for the FIB-4 score that is in line with recent studies [ 23 , 24 ].…”
Section: Discussionsupporting
confidence: 90%
“…In agreement with current knowledge ( Supplementary Table 4 ), well-known cardiovascular biomarkers such as ultrasensitive troponin ( Zhu et al, 2021 ), C-reactive protein, and lactic dehydrogenase were increased in the groups with fatal outcome ( Supplementary Table 4 ). Our work reinforces the role of other less well identified biomarkers such as hepatic features ( Ramos-Lopez et al, 2021 ) and pulmonary artery diameters ( Spagnolo et al, 2020 ). We also provide evidence that several biomarkers could benefit from adjusted thresholds by sex such as ferritin, respectively ( Supplementary Table 4 ).…”
Section: Discussionsupporting
confidence: 83%
“…A specific implication of severe COVID-19 in NAFLD patients putatively mediated by immunocompetence status is highlighted in the B cluster, where transaminases and liver health markers showed abnormal values and may drive personalized medicine approaches, as prompted by the allocation to a cluster with related measurements uncovering therapeutic targets. In a previous report, patients concerning this COVID-DATA-SAFE-LIFES cohort were categorized following conventional criteria to explain disease severity and deaths, which verified that liver and proinflammatory features are important determinants of COVID-19 morbidity and mortality in order to ameliorate the understanding of morbid manifestations of COVID-19, besides to help the therapy decision-making protocols under a personalized medicine scope [ 11 ]. Indeed, the liver health and coagulation axis appears as a relevant surrogate for elucidating some COVID-19 outcomes linked to systemic inflammation [ 43 ], as well as thrombotic and fibrinolytic disturbances [ 44 ], which were deciphered in the currently emerged three clusters, including some markers of global health such as lactate dehydrogenase or creatinine/urea measurements [ 45 ], as particularly discriminated in Cluster C. Interestingly, hemoglobin and prothrombin values evidenced divergent patterns after the following 72-h period, which represent a worth for a cluster monitor.…”
Section: Discussionmentioning
confidence: 69%
“…The delay of detection and hospitalization has a large impact on the concurrent inflammatory stage, and, thus, on the prognosis and the fatality of the disease [ 7 ]. These manifestations are accompanied by microvascular damages caused by the cytokine “storm” [ 8 ], and often, the pathophysiological COVID-19 condition is also associated with bacterial infections [ 9 ] and with body metabolic impairments [ 10 , 11 ], where prescribed anti-inflammatory medications also may play a role [ 12 ].…”
Section: Introductionmentioning
confidence: 99%